DKK 7.0
(2.04%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 24.55 Million DKK | 40.0% |
2022 | 17.53 Million DKK | -13.3% |
2021 | 20.22 Million DKK | -47.11% |
2020 | 38.24 Million DKK | -15.3% |
2019 | 45.15 Million DKK | -28.8% |
2018 | 63.42 Million DKK | 1174.07% |
2017 | 4.97 Million DKK | -58.51% |
2016 | 11.99 Million DKK | -31.11% |
2015 | 17.41 Million DKK | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 20.17 Million DKK | -17.83% |
2024 Q2 | 15.96 Million DKK | -20.9% |
2023 Q2 | 15.9 Million DKK | 12.7% |
2023 Q4 | 24.55 Million DKK | 68.74% |
2023 Q1 | 14.11 Million DKK | -19.53% |
2023 Q3 | 14.55 Million DKK | -8.51% |
2023 FY | 24.55 Million DKK | 40.0% |
2022 Q1 | 17.48 Million DKK | -13.56% |
2022 FY | 17.53 Million DKK | -13.3% |
2022 Q4 | 17.53 Million DKK | -11.74% |
2022 Q3 | 19.87 Million DKK | 50.92% |
2022 Q2 | 13.16 Million DKK | -24.7% |
2021 Q3 | 23.29 Million DKK | -16.67% |
2021 Q1 | 29.67 Million DKK | -22.4% |
2021 FY | 20.22 Million DKK | -47.11% |
2021 Q4 | 20.22 Million DKK | -13.17% |
2021 Q2 | 27.95 Million DKK | -5.79% |
2020 Q2 | 43.69 Million DKK | 11.34% |
2020 FY | 38.24 Million DKK | -15.3% |
2020 Q3 | 43.02 Million DKK | -1.55% |
2020 Q4 | 38.24 Million DKK | -11.1% |
2020 Q1 | 39.24 Million DKK | -13.09% |
2019 Q2 | 56.4 Million DKK | -6.19% |
2019 FY | 45.15 Million DKK | -28.8% |
2019 Q4 | 45.15 Million DKK | -13.93% |
2019 Q3 | 52.46 Million DKK | -6.99% |
2019 Q1 | 60.13 Million DKK | -5.18% |
2018 Q1 | 14.18 Million DKK | 184.93% |
2018 FY | 63.42 Million DKK | 1174.07% |
2018 Q3 | 68.14 Million DKK | -10.04% |
2018 Q4 | 63.42 Million DKK | -6.93% |
2018 Q2 | 75.75 Million DKK | 434.08% |
2017 Q1 | - DKK | 0.0% |
2017 Q4 | 4.97 Million DKK | 0.0% |
2017 FY | 4.97 Million DKK | -58.51% |
2016 FY | 11.99 Million DKK | -31.11% |
2015 FY | 17.41 Million DKK | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Ambu A/S | 6.85 Billion DKK | 99.642% |
ChemoMetec A/S | 676.67 Million DKK | 96.371% |
Demant A/S | 30.54 Billion DKK | 99.92% |
GN Store Nord A/S | 30.64 Billion DKK | 99.92% |
Scandinavian Medical Solutions A/S | 163.96 Million DKK | 85.024% |